0.0567USDMkt Cap: —P/E: —1d ago
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…
Industry Peers
Health Care Equipment & SuppliesIndicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)545.76M $
Gross Profit82.50M $
Net Income (TTM)-36.32M $
Revenue/Share5.537 USD
Last Price0.0567 USD
Fiscal Year End—
MR Quarter—
Employees641
CountryUS
SectorHealthcare
IndustryHealth Care Equipment & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.35
EPS (TTM)—
EPS (Forward)—
52W Range
0.049876% of range0.0589
52W High0.0589 USD
52W Low0.0498 USD
Profitability
Gross Margin15.12%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-7.97%
ROE—
ROA-12.30%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.81M $
CapEx (TTM)—
FCF Margin-2.81%
FCF Yield—
Net Debt74.63M $
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity—
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1630 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float86.67M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.42
S&P 52W Chg18.95%
Avg Vol (30d)17.21K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—